Mitsuo Terada, MD, PhD@乳腺科医· @MamMa_mimumemo · X·· 21 小时前评分45
正文
Anbenitamab+albumin-bound DTXのHEALER試験。
Anbenitamabは、中国のHER2 domain IIとdomain IVのbispecific抗体らしい。
THPに対して、有意にPFSを延長。OSも延長傾向。
#ESMO26
123 浏览 · 2 赞 · 1 转发 · 0 回复
会议摘要
LBA15按 Proffered paper 2: Breast cancer, early and advanced stage 对上
Anbenitamab plus albumin-bound docetaxel in patients (pts) with HER2-positive advanced breast cancer (BC): A randomized phase III study
https://esmocongress.esmo.orgLBA80按 Rapid oral 1: Gastrointestinal tumour, upper digestive 对上
Anbenitamab plus chemotherapy for previously treated HER2-positive gastric or gastroesophageal carcinomas (GC/GEJC): Updated overall survival (OS) analysis of KC-WISE
https://esmocongress.esmo.org来源：Mitsuo Terada, MD, PhD@乳腺科医 · x.com